- Home
- SAM vs CPRX Comparison
SAM vs CPRX Comparison
Compare SAM & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAM
- CPRX
- Stock Information
- Founded
- SAM 1984
- CPRX 2002
- Country
- SAM United States
- CPRX United States
- Employees
- SAM N/A
- CPRX N/A
- Industry
- SAM Beverages (Production/Distribution)
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- SAM Consumer Staples
- CPRX Health Care
- Exchange
- SAM Nasdaq
- CPRX Nasdaq
- Market Cap
- SAM 2.4B
- CPRX 2.6B
- IPO Year
- SAM 1995
- CPRX 2006
- Fundamental
- Price
- SAM $223.59
- CPRX $20.40
- Analyst Decision
- SAM Hold
- CPRX Strong Buy
- Analyst Count
- SAM 10
- CPRX 5
- Target Price
- SAM $254.89
- CPRX $33.20
- AVG Volume (30 Days)
- SAM 221.3K
- CPRX 1.5M
- Earning Date
- SAM 10-23-2025
- CPRX 11-05-2025
- Dividend Yield
- SAM N/A
- CPRX N/A
- EPS Growth
- SAM N/A
- CPRX 183.96
- EPS
- SAM 6.99
- CPRX 1.65
- Revenue
- SAM $2,049,593,000.00
- CPRX $558,499,000.00
- Revenue This Year
- SAM N/A
- CPRX $16.51
- Revenue Next Year
- SAM $1.46
- CPRX $9.58
- P/E Ratio
- SAM $32.30
- CPRX $12.31
- Revenue Growth
- SAM 2.46
- CPRX 28.55
- 52 Week Low
- SAM $185.34
- CPRX $19.15
- 52 Week High
- SAM $329.55
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- SAM 54.68
- CPRX 51.31
- Support Level
- SAM $214.01
- CPRX $19.66
- Resistance Level
- SAM $229.12
- CPRX $20.42
- Average True Range (ATR)
- SAM 5.29
- CPRX 0.67
- MACD
- SAM -0.15
- CPRX 0.06
- Stochastic Oscillator
- SAM 57.13
- CPRX 60.89
About SAM Boston Beer Company Inc. (The)
Boston Beer is a top player in high-end malt beverages and adjacent categories in the US, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates almost all sales in the US.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).